Mycenax as a bio-CMC based company, we are focusing on: 1) CDMO service, and 2) biological drug development including new biologics entities and biosimilars
For CDMO services, we offer a one-stop shop and fully-integrated solution to serve various needs. Our facilities are PIC/S GMP certified and registered in USFDA, MHLW and Accreditation of Foreign Manufacturers (AFM). Furthermore, our technology is leading the trend and also was Shortlisted in 2018 CPhI awards.
For biological drug development, we have more than 10 pipelines mainly covered the field of oncology and autoimmune disease. The pipelines below are currently open for partnering.